CLOV 1D - Health Is Back in Trend

On the daily chart, Clover Health (CLOV) has broken out of its descending channel and triangle, now pulling back for a retest near 3.27–3.43 - a key buy zone aligned with the MA50. Buyers are clearly regaining control, and the setup looks ready for continuation.

Technically:

– first clean breakout of the downtrend since January 2025;
– volume expansion on bullish candles, suggesting institutional accumulation;
– holding above the former resistance turned support.

Upside targets: $4.71 (local volume peak) and $5.98, offering +70% potential upside if momentum sustains.

From a fundamental perspective, Clover Health is stabilizing its business:

– a leading player in Medicare Advantage, with an expanding senior member base;
– Q3 results show 40% reduction in net loss and +18% YoY revenue growth;
– leveraging AI-driven healthcare analytics to improve efficiency and patient outcomes;
– with high short interest, a confirmed breakout above $4.70 could ignite a short squeeze.

Tactical plan: accumulation near 3.27–3.43, add above 4.70, targets 4.71 → 5.98. Sometimes the healthiest trend is the bullish one.